NOVEL CRYSTALLINE FORM OF A DIHYDROCHLORIDE SALT OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
The present invention relates to a novel crystalline form of the dihydrochloride salt of (2R,3S,5S)-2-(2,5-difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tetrahydro-2H-pyran-3-amine as well as a process for its preparation, pharmaceutical compositions containing this novel form, and me...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
29.01.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a novel crystalline form of the dihydrochloride salt of (2R,3S,5S)-2-(2,5-difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tetrahydro-2H-pyran-3-amine as well as a process for its preparation, pharmaceutical compositions containing this novel form, and methods of use of the novel form and pharmaceutical compositions for the treatment of Type 2 diabetes, hyperglycemia, insulin resistance, obesity, and high blood pressure.
La présente invention porte sur une nouvelle forme cristalline du sel de dichlorhydrate de (2R,3S,5S)-2-(2,5-difluorophényl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tétrahydro-2H-pyran-3-amine, ainsi que sur un procédé pour sa préparation, sur des compositions pharmaceutiques contenant cette nouvelle forme et sur des procédés d'utilisation de la nouvelle forme et des compositions pharmaceutiques pour le traitement du diabète de type 2, de l'hyperglycémie, de la résistance à l'insuline, de l'obésité et de l'hypertension. |
---|---|
Bibliography: | Application Number: WO2008US08859 |